¼¼°èÀÇ ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿öÅ©Ç÷ο캰, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants), By Workflow (Upstream, Downstream), By End Use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1771532
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,251,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,638,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,411,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 15.44%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 740¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì¿¡ ´ëÇÑ ¼ö¿ä´Â ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º Á¶ÀÛ¿¡ ÇÊ¿äÇÑ ºñ¿ë°ú ½Ã°£ ´ÜÃà µî »ó¾÷Àû ÀÌÁ¡ÀÌ Á¦°øµÈ´Ù´Â Á¡ÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿ø·¡ ´ÜŬ·ÐÇ×ü »ý»ê¿¡ »ç¿ëµÇ´ø ÀÏȸ¿ë ±â¼úÀº ¼¼Æ÷ Ä¡·áÁ¦ ¹× À¯ÀüÀÚ Ä¡·áÁ¦ »ý»ê¿¡µµ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ¹ÙÀÌ¿À Á¦Á¶ ¾÷¹«¿¡ ´ëÇÑ Àû¿ë ¹üÀ§°¡ ³Ð¾îÁö°í, »ê¾÷ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê°¡ ¾÷°èÀÇ ¼ºÀå Àü¸ÁÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 7¿ù, Cytiva¿Í Pall Corp.´Â 2³â°£ÀÇ »ý»ê´É·Â È®´ë¸¦ À§ÇÑ ÅõÀÚ °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù. ´Ù¸¥ ÁÖ¿ä Á¦Ç° Áß ¸ÂÃãÇü Ä¡·á¿¡ »ç¿ëµÇ´Â ¼¼Æ÷ ÆØÃ¢¿ë ¹ÙÀÌ¿À¸®¾×ÅÍ ¹é ¹× °úÇÐ ¿¬±¸¿ë ÁÖ»ç±â ÇÊÅÍ¿Í °°Àº ÀÏȸ¿ë ±â¼ú¿¡ 3¾ï ´Þ·¯ ÀÌ»óÀÌ ÅõÀڵǾú½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ÀÚü »ý»ê ¹× À§Å¹ »ý»ê¿¡¼­ ÀÏȸ¿ë ÀåºñÀÇ Ã¤Åà Ȯ´ë´Â ÀÌ ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ È帧¿¡ »õ·Î¿î ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ÇÁ·Îºê ¹× ¼¾¼­, ±³¹Ý ½Ã½ºÅÛ, ¹ÙÀÌ¿À¸®¾×ÅÍ ¼³°è, ¿©°ú ±â¼ú µî ¿©·¯ Á¦Ç° Æ÷Æ®Æú¸®¿À¿¡¼­ »ó´çÇÑ ÁøÀüÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌ´Â ¼öÀÍÀÇ °­·ÂÇÑ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½Ã½ºÅÛÀÌ Á¦°øÇÏ´Â ÀÌÁ¡À» ÅëÇØ ¹ÙÀÌ¿À Á¦¾à»çµéÀº ´ÙǰÁ¾ »ý»ê ½Ã¼³ÀÇ µµÀÔ, ÆÄÆ®³Ê½Ê ü°á, ÆÄÀÌÇÁ¶óÀÎ Á¦Ç°ÀÇ À§Å¹ °³¹ß ¹× Á¦Á¶ ¾Æ¿ô¼Ò½Ì µîÀ» ÅëÇØ º¸´Ù ½Å¼ÓÇÏ°Ô Á¦Ç°À» ½ÃÀå¿¡ Ãâ½ÃÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 1¿ù À߯®¸®¿ì½º AG´Â Àΰ£ °£¿±Áٱ⼼Æ÷(hMSC)ÀÇ ÁÖ¿ä °ø±Þ¾÷üÀÎ ·ç½ºÅÍ ¹ÙÀÌ¿À(Rooster Bio)¿Í ÆÄÆ®³Ê½ÊÀ» ü°áÇÏ¿´½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â Zaltrius AGÀÇ ÀÏȸ¿ë Á¦Á¶ ±â¼úÀ» Ȱ¿ëÇÏ¿© ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·áÁ¦ Á¦Á¶¸¦ ÃËÁøÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀº ¾÷°èÀÇ ÁÖ¿ä ÀÌÇØ°ü°èÀڵ鿡°Ô »õ·Î¿î ¼ºÀå ±âȸ¸¦ °¡Á®´ÙÁÖ¾ú½À´Ï´Ù.

ÁÖ¿ä ¹ÙÀÌ¿À Á¦¾à»çµéÀº ÀÏȸ¿ë ¹ÙÀÌ¿À °øÁ¤ Àåºñ¸¦ µµÀÔÇÏ°í »ý»ê ½Ã¼³À» È®ÀåÇÏ¿© COVID-19 °ü·Ã Á¦Ç° °ø±ÞÀ» È®´ëÇÔÀ¸·Î½á ÀÌ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. »ó´ç¼öÀÇ ¹ÙÀÌ¿ÀÁ¦¾à±â¾÷µéÀÌ COVID-19 ¹é½Å °³¹ß ¹× »ý»ê¿¡ Àû±Ø ³ª¼­°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·Î±×·¥Àº ÁÖ·Î ÀÏȸ¿ë ±â¼úÀ» ±â¹ÝÀ¸·Î Çϰí Àִµ¥, ÀÌ´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÌ À¯¿¬ÇÏ°í ºñ¿ë È¿À²ÀûÀÌ¸ç ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. »ê¾÷ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ¿öÅ©Ç÷ο캰 ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ÀÏȸ¿ë ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Single-use Bioprocessing Market Growth & Trends:

The global single-use bioprocessing market size is projected to reach USD 74.09 billion by 2030, registering a CAGR of 15.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

Key biopharmaceutical players can leverage the opportunity by expanding their COVID-19-related product offerings by scaling up their production facilities with the implementation of single-use bioprocessing equipment. A significant number of biopharmaceutical companies are actively involved in the development and production of COVID-19 vaccines. These programs are majorly based on single-use technologies as these systems are flexible, cost-effective, and reduce the risk of cross-contamination. Such an ongoing and continuous increase in the adoption of bioprocessing systems due to the COVID-19 pandemic is anticipated to drive industry growth.

Single-use Bioprocessing Market Report Highlights:

Table of Contents

Chapter 1. Single-use Bioprocessing Market: Research Methodology and Scope

Chapter 2. Single-use Bioprocessing Market: Executive Summary

Chapter 3. Market Variables, Trends, and Scope

Chapter 4. Single-use Bioprocessing Market: Product Estimates & Trend Analysis

Chapter 5. Single-use Bioprocessing Market: Workflow Estimates & Trend Analysis

Chapter 6. Single-use Bioprocessing Market: End Use Estimates & Trend Analysis

Chapter 7. Single-use Bioprocessing Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â